Psychedelics Today, Author at PsyNews.com

Home Authors Posts by admin

2161 POSTS 0 COMMENTS

https://psynews.com

Self-Care, Destabilization, and the Holistic Nature of Psychedelics

Expanding Psychedelic Clinical Trials to LGBTQ+ Populations

An Inside Look at the FDA and Early Drug Development

In Conversation: Joanna Kempner, Author of “Psychedelic Outlaws: The Movement Revolutionizing...

Community, Group Process, and Co-Creation: How to Build a Successful Retreat

Pα+ Psychedelic Bulletin #164: Lykos Dominates News Cycle; EPIsoDE Trial Readout;...

Breaking: Lykos Therapeutics Moved to Patent MDMA In Late 2022, Filing...

Why Are Some Parents Choosing Psychedelics Over SSRIs for Teens?

Natural Medicine Advisory Bulletin 11.5: Rule Review & Roadmap

From the Eleusinian Mysteries to Modern Mysticism: The Role of Religion...

1...161718...217 Page 17 of 217

Pα+ Psychedelic Bulletin #185: Joe Rogan on Ibogaine; Wisconsin Medicaid to...

Billionaire Investor Antonio Gracias Plots $100M Lykos Takeover with Doblin’s Backing

Can Legalization Serve the Greater Good? The Ethical Challenges of Psychedelic...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin